Related Experiment Video
Updated: May 13, 2026
In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
Assessing coronary microvascular dysfunction in refractory no-reflow: Insights from dynamic myocardial perfusion
Stanislav Dil1, Vyacheslav Ryabov1, Leonid Maslov1
1Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.
Insights
Refractory no-reflow is linked to elevated left ventricular end-diastolic pressure (LVEDP) and reduced global relative flow increase (gRFI), identified through advanced imaging. These findings suggest gRFI as a potential non-invasive marker for microvascular dysfunction.
Area of Science:
- Cardiology
- Medical Imaging
- Physiology
Background:
- Refractory no-reflow after percutaneous coronary intervention (PCI) is associated with poor patient outcomes, including larger infarct sizes and increased mortality.
- Microvascular obstruction (MVO) and elevated left ventricular end-diastolic pressure (LVEDP) are key contributors to the pathophysiology of refractory no-reflow.
- Current invasive methods like Index of Microcirculatory Resistance (IMR) have limitations in widespread adoption, necessitating non-invasive alternatives.
Purpose of the Study:
- To investigate the association between functional and structural markers of microvascular dysfunction in patients with refractory no-reflow.
- To evaluate the utility of dynamic SPECT and cardiac MRI in assessing coronary microvascular function non-invasively.
- To explore the potential of global relative flow increase (gRFI) as a non-invasive marker for microvascular impairment.
Main Methods:
- Post hoc analysis of a randomized controlled trial involving patients with refractory no-reflow post-PCI.
- Utilized dynamic SPECT to assess global coronary flow metrics (RMBF, SMBF, gRFI).
- Assessed structural markers of microvascular injury (infarct size, MVO) using cardiac MRI and echocardiographic estimations of LVEDP.
Main Results:
- Dynamic SPECT indicated suboptimal stress myocardial blood flow in most patients, suggesting microvascular impairment.
- Elevated LVEDP showed a significant correlation with indexed MVO (r=0.678, p=0.001).
- Global relative flow increase (gRFI) demonstrated a statistically significant correlation with MVO, outperforming traditional flow reserve metrics in detecting stress-induced perfusion abnormalities.
Conclusions:
- Functional impairments, specifically elevated LVEDP and reduced gRFI, are associated with refractory no-reflow.
- gRFI shows promise as a non-invasive biomarker for microvascular dysfunction, complementing structural imaging.
- Further validation in larger cohorts is required; refined multimodal imaging and targeted therapies are advocated to improve outcomes.
Background:
Refractory no-reflow correlates with worse outcomes, including larger infarct sizes, impaired ventricular function, and higher mortality rates, despite advances in percutaneous coronary intervention (PCI). Microvascular obstruction (MVO) and increased left ventricular end-diastolic pressure (LVEDP) are implicated in the pathogenesis, potentially exacerbating ischemic injury and limiting myocardial recovery. While pressure-wire-derived indices such as the Index of Microcirculatory Resistance (IMR) have been validated against MRI-defined MVO in STEMI populations, their invasive nature and procedural complexity limit broad adoption. In contrast, combining dynamic SPECT and cardiac MRI enables a comprehensive non-invasive functional-structural evaluation of coronary microvascular function in refractory no-reflow.
Methods:
This study is a post hoc analysis of a larger randomized controlled trial (RCT) evaluating the efficacy and safety of intracoronary epinephrine in patients with refractory no-reflow post-PCI (ClinicalTrials.govNCT04573751). We evaluated global coronary flow metrics (RMBF, SMBF, gRFI) derived from SPECT and assessed structural markers of microvascular injury (infarct size, MVO) on MRI. Echocardiographic estimations of LVEDP were also analyzed.
Results:
Dynamic SPECT revealed suboptimal stress myocardial blood flow in most patients, highlighting microvascular impairment. Elevated estimated LVEDP was significantly correlated with indexed MVO (rs = 0.678, p = 0.001). Traditional flow reserve metrics showed limited sensitivity, whereas global relative flow increase (gRFI) showed a statistically significant correlation with MVO, highlighting its added value in detecting stress-induced perfusion abnormalities. Given the small sample and potential outlier influence, this observation should be considered hypothesis-generating.
Conclusion:
Our findings support that functional impairments-particularly elevated LVEDP and reduced gRFI-are associated with refractory no-reflow. In particular, gRFI may serve as a promising non-invasive marker of microvascular dysfunction, complementing structural imaging. None-theless, further validation in larger cohorts is needed. This study advocates for refined multimodal imaging strategies and tailored therapeutic approaches targeting dynamic microvascular disturbances to improve outcomes in refractory no-reflow.
More Related Videos
08:35Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
05:07Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice
Published on: August 25, 2023
